|
gptkbp:instanceOf
|
hormone
|
|
gptkbp:administeredBy
|
injection
|
|
gptkbp:aminoAcidLength
|
29
|
|
gptkbp:approvedDrugIn
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:CASNumber
|
16941-32-5
|
|
gptkbp:category
|
peptide
hyperglycemic agent
|
|
gptkbp:discoveredBy
|
gptkb:C.P._Kimball
|
|
gptkbp:discoveredIn
|
1923
|
|
gptkbp:encodedBy
|
gptkb:GCG_gene
|
|
gptkbp:enemyOf
|
gptkb:insulin
|
|
gptkbp:foundIn
|
vertebrates
|
|
gptkbp:halfLife
|
3–6 minutes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
glucagon
|
|
gptkbp:improves
|
blood sugar
|
|
gptkbp:inhibitedBy
|
gptkb:insulin
gptkb:somatostatin
high blood glucose
glycogenesis
|
|
gptkbp:MeSH_ID
|
D005951
|
|
gptkbp:producedBy
|
pancreas
alpha cells
|
|
gptkbp:promotion
|
glycogenolysis
gluconeogenesis
low blood glucose
|
|
gptkbp:PubChem_CID
|
16132397
CHEMBL1201280
DB00013
|
|
gptkbp:recipient
|
gptkb:glucagon_receptor
|
|
gptkbp:regulates
|
blood glucose
|
|
gptkbp:structure
|
polypeptide
|
|
gptkbp:UNII
|
7J22XCU6YG
|
|
gptkbp:usedAsDrugFor
|
severe hypoglycemia
|
|
gptkbp:usedInTreatmentOf
|
beta-blocker overdose
calcium channel blocker overdose
|
|
gptkbp:bfsParent
|
gptkb:G_protein-coupled_receptors_(Class_IB)
gptkb:cAMP_pathway
gptkb:glucagon_receptor
gptkb:insulin
gptkb:Islets_of_Langerhans
gptkb:glycogen
gptkb:pancreatic_neuroendocrine_tumors
gptkb:hormone
|
|
gptkbp:bfsLayer
|
6
|